We are live on ! Find out more
BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $289B
1-Year Est. Return 60.46%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Fund
S&P 500
This Quarter Est. Return
-13.64%
1 Year Est. Return
+60.46%
3 Year Est. Return
+148.24%
5 Year Est. Return
+163.86%
10 Year Est. Return
+570.16%
AUM
$42.3B
AUM Growth
-$25.4B
Cap. Flow
-$18.9B
Cap. Flow %
-44.7%
Top 10 Hldgs %
18.81%
Holding
4,572
New
126
Increased
1,431
Reduced
2,296
Closed
248

Sector Composition

Rank Sector Weight
1 Technology 7%
2 Financials 5.86%
3 Healthcare 5.05%
4 Consumer Discretionary 4.98%
5 Industrials 3.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HOS
3851
DELISTED
Hornbeck Offshore Services, Inc.
HOS
$789 ﹤0.01%
+548
New +$1.92K
ZYNE
3852
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$787 ﹤0.01%
265
-6
-2% -$33
HSTO
3853
DELISTED
Histogen Inc. Common Stock
HSTO
$785 ﹤0.01%
2
CRVS icon
3854
Corvus Pharmaceuticals
CRVS
$1.27B
$767 ﹤0.01%
209
-209
-50% -$1.43K
CBPO
3855
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$759 ﹤0.01%
10
CHAP
3856
DELISTED
Chaparral Energy, Inc.
CHAP
$758 ﹤0.01%
+154
New +$1.96K
CLDX icon
3857
Celldex Therapeutics
CLDX
$3.35B
$756 ﹤0.01%
255
+74
+41% +$363
MARK
3858
DELISTED
Remark Holdings, Inc.
MARK
$749 ﹤0.01%
62
-27
-30% -$588
VBIV
3859
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$741 ﹤0.01%
15
+2
+15% +$110
AMPE
3860
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$740 ﹤0.01%
6
-3
-33% -$460
YORW icon
3861
York Water
YORW
$536M
$737 ﹤0.01%
23
-417
-95% -$13.4K
HIND
3862
Vyome Holdings
HIND
$15.2M
0
UNB icon
3863
Union Bankshares
UNB
$122M
$716 ﹤0.01%
15
-124
-89% -$5.84K
NEXT icon
3864
NextDecade
NEXT
$1.8B
$713 ﹤0.01%
132
-118
-47% -$596
OPB
3865
DELISTED
Opus Bank Common Stock
OPB
$705 ﹤0.01%
36
-2,854
-99% -$60.9K
ASCMA
3866
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
$702 ﹤0.01%
1,800
-194
-10% -$188
BATRK icon
3867
Atlanta Braves Holdings Series B
BATRK
$3.41B
$697 ﹤0.01%
28
-1,190
-98% -$30.1K
ASUR icon
3868
Asure Software
ASUR
$251M
$686 ﹤0.01%
135
-188
-58% -$1.55K
CIX icon
3869
Comp X International
CIX
$390M
$680 ﹤0.01%
50
+49
+4,900% +$664
OMER icon
3870
Omeros
OMER
$1.26B
$680 ﹤0.01%
61
-1,550
-96% -$21.7K
LEAF
3871
DELISTED
Leaf Group Ltd.
LEAF
$678 ﹤0.01%
99
-736
-88% -$6.32K
TRVN
3872
DELISTED
Trevena, Inc.
TRVN
$670 ﹤0.01%
2
UBP
3873
DELISTED
Urstadt Biddle Properties Inc.
UBP
$663 ﹤0.01%
44
-2
-4% -$33
CTIC
3874
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$662 ﹤0.01%
902
-768
-46% -$1.26K
MJCO
3875
DELISTED
Majesco
MJCO
$659 ﹤0.01%
93
-84
-47% -$611

Similar funds

BNP Paribas Financial Markets's Q4 2018 Portfolio in Review

As of Q4 2018, BNP Paribas Financial Markets held 4,572 positions worth $42.3B, down 38% from $67.7B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

BNP Paribas Financial Markets withdrew a net $18.9B in Q4 2018, closing 248 positions and reducing 2,296 holdings. Its most notable exit was Aetna Inc, an estimated $141M position sold in full.

By sector, the portfolio is most concentrated in Technology at 7% of assets, down from 9.5% a quarter earlier, followed by Financials and Healthcare.

Against the trend, BNP Paribas Financial Markets opened a new position in HUTCHMED worth $8.84M.

  • BNP Paribas Financial Markets's largest Q4 2018 buy was HUTCHMED: 382,749 shares worth $8.84M.
  • BNP Paribas Financial Markets added most to Celgene Corp in Q4 2018, an estimated $151M increase.
  • BNP Paribas Financial Markets's biggest Q4 2018 reduction was Alphabet (Google) Class C, cutting an estimated $1.15B.
  • BNP Paribas Financial Markets fully exited Aetna Inc in Q4 2018, selling an estimated $141M.
  • BNP Paribas Financial Markets's ten largest holdings make up 19% of its $42.3B portfolio in Q4 2018.
  • BNP Paribas Financial Markets opened 126 new positions and closed 248 in Q4 2018.
  • BNP Paribas Financial Markets's portfolio value fell 38% quarter-over-quarter to $42.3B.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2018, filed 12 Feb 2019.